APA (7th ed.) Citation

TA, D., SK, M., & CE, W. (2025). Hitting the Sweet Spot: The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis. American journal of respiratory and critical care medicine, 211(10), 1896. https://doi.org/10.1164/rccm.202508-1884ED

Chicago Style (17th ed.) Citation

TA, Douglas, McMahon SK, and Wainwright CE. "Hitting the Sweet Spot: The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis." American Journal of Respiratory and Critical Care Medicine 211, no. 10 (2025): 1896. https://doi.org/10.1164/rccm.202508-1884ED.

MLA (9th ed.) Citation

TA, Douglas, et al. "Hitting the Sweet Spot: The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis." American Journal of Respiratory and Critical Care Medicine, vol. 211, no. 10, 2025, p. 1896, https://doi.org/10.1164/rccm.202508-1884ED.